Literature DB >> 27474091

Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Maria C Olianas1, Simona Dedoni1, Pierluigi Onali2.   

Abstract

BACKGROUND AND
PURPOSE: Although clinically useful for their immunomodulatory, antiproliferative and antiviral properties, type I interferons (IFNs) are involved in the pathogenesis of several neurodegenerative/neuroinflammatory diseases. In the present study, we investigated the ability of cholinergic stimulation to protect from IFN-β-induced neuronal apoptosis. EXPERIMENTAL APPROACH: The effects of the ACh receptor agonist carbachol (CCh) on IFN-β-induced apoptosis of human SH-SY5Y neuroblastoma cells were examined by using western blots, immunofluorescence and cytofluorimetry. The involvement of muscarinic acetylcholine receptors (mAChRs) was assessed by using selective antagonists and siRNA transfection. Pharmacological inhibitors and overexpression of ERK2 and an ERK2 constitutively active form (ERK2-CA) were employed to study ERK1/2 signalling. The effects of oxotremorine-M (Oxo-M) on IFN-β-induced apoptosis of mouse hippocampal neurons were examined by measuring cleaved caspase 3 expression. KEY
RESULTS: In SH-SY5Y cells, CCh inhibited IFN-β-induced mitochondrial cytochrome c release, activation of caspases 9, 7 and 3, PARP cleavage and DNA fragmentation. The anti-apoptotic effect of CCh was mediated by M3 receptors, blocked by Gq/11 antagonist YM254890 and PKC inhibitor Go 6983, impaired by inhibition of ERK1/2 pathway, potentiated by overexpression of ERK2 and mimicked by ERK2-CA. Blockade of JNK activation enhanced the CCh anti-apoptotic response. IFN-β inhibited JNK activation and up-regulated CCh-induced ERK1/2 signalling. In hippocampal neurons, Oxo-M reduced IFN-β-induced apoptosis; this effect was antagonized by blockade of M1 /M3 receptors and ERK1/2. CONCLUSIONS AND IMPLICATIONS: Stimulation of mAChRs counteracted IFN-β-induced neuronal apoptosis through the activation of ERK1/2 signalling. The data indicate that activation of ERK1/2-coupled mAChRs may be an effective strategy for preventing IFNs neurotoxicity.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27474091      PMCID: PMC5055140          DOI: 10.1111/bph.13570

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  68 in total

1.  Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Eur J Pharmacol       Date:  2011-04-19       Impact factor: 4.432

Review 2.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

3.  Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

Review 4.  Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha.

Authors:  I L Campbell; T Krucker; S Steffensen; Y Akwa; H C Powell; T Lane; D J Carr; L H Gold; S J Henriksen; G R Siggins
Journal:  Brain Res       Date:  1999-07-17       Impact factor: 3.252

Review 5.  Type I interferon in neurological disease-the devil from within.

Authors:  Markus J Hofer; Iain L Campbell
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

6.  Epitope-tagged Gq alpha subunits: expression of GTPase-deficient alpha subunits persistently stimulates phosphatidylinositol-specific phospholipase C but not mitogen-activated protein kinase activity regulated by the M1 muscarinic acetylcholine receptor.

Authors:  N X Qian; S Winitz; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

Review 7.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 8.  AMPK in the brain: its roles in energy balance and neuroprotection.

Authors:  Gabriele V Ronnett; Santosh Ramamurthy; Amy M Kleman; Leslie E Landree; Susan Aja
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function.

Authors:  Kuti Baruch; Aleksandra Deczkowska; Eyal David; Joseph M Castellano; Omer Miller; Alexander Kertser; Tamara Berkutzki; Zohar Barnett-Itzhaki; Dana Bezalel; Tony Wyss-Coray; Ido Amit; Michal Schwartz
Journal:  Science       Date:  2014-08-21       Impact factor: 47.728

10.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more
  5 in total

1.  Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

Review 2.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

3.  Muscarinic Acetylcholine Receptors Potentiate 5'-Adenosine Monophosphate-Activated Protein Kinase Stimulation and Glucose Uptake Triggered by Thapsigargin-Induced Store-Operated Ca2+ Entry in Human Neuroblastoma Cells.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Neurochem Res       Date:  2017-10-09       Impact factor: 3.996

4.  Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes.

Authors:  Maria J Fernández-Cabezudo; Junu A George; Ghada Bashir; Yassir A Mohamed; Alreem Al-Mansori; Mohammed M Qureshi; Dietrich E Lorke; Georg Petroianu; Basel K Al-Ramadi
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

5.  An experimental strategy to probe Gq contribution to signal transduction in living cells.

Authors:  Julian Patt; Judith Alenfelder; Eva Marie Pfeil; Jan Hendrik Voss; Nicole Merten; Funda Eryilmaz; Nina Heycke; Uli Rick; Asuka Inoue; Stefan Kehraus; Xavier Deupi; Christa E Müller; Gabriele M König; Max Crüsemann; Evi Kostenis
Journal:  J Biol Chem       Date:  2021-02-24       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.